Showing results (1521-1530 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|June 7, 2019
Cardiorespiratory fitness in patients with rheumatoid arthritis is associated with the patient global assessment but not with objective measurements of disease activityMarthe Halsan Liff, Mari Hoff, Thomas Fremo, et al.
RMD Open|June 28, 2019
Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona RegistryPhilip J Mease, Carol J Etzel, William J Huster, et al.
RMD Open|June 28, 2019
Arthropathy of Down syndrome: an under-diagnosed inflammatory joint disease that warrants a name changeCharlene M Foley, Derek A Deely, Emma Jane MacDermott, et al.
RMD Open|June 28, 2019
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 studyJoachim Sieper, Robert Landewé, Marina Magrey, et al.
RMD Open|June 28, 2019
Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohortManuel Francisco Ugarte-Gil, Guillermo J Pons-Estel, Luis M Vila, et al.
RMD Open|February 18, 2022
Measuring quality of life of patients with axial spondyloarthritis for economic evaluationMonica Hernandez Alava, Allan Wailoo, Georgios Chrysanthou, et al.
RMD Open|February 18, 2022
Impact of synovial biopsy procedures and disease-specific aspects on synovial tissue outcome: a systematic literature review informing the EULAR points to consider for the minimal reporting requirements in synovial tissue research in rheumatologyAurélie Najm, Félicie Costantino, Catherine Weill, et al.
RMD Open|March 17, 2022
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studiesChristopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, et al.
RMD Open|March 30, 2022
Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDsMaud Wieczorek, James Martin Gwinnutt, Maxime Ransay-Colle, et al.
RMD Open|September 1, 2018
Towards secondary prevention of early knee osteoarthritisArmaghan Mahmoudian, Dieter Van Assche, Walter Herzog, et al.
Pageof 192